AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-making
{{output}}
Background: US payers are interested in incorporating real-world evidence (RWE) into their pharmaceutical coverage and reimbursement decisions. One barrier to using RWE to inform decisions is the lack of standards for RWE assessm... ...
